InCephalo

Blood & Organ Banks · Switzerland · 1-10 Employees

View Company Info for Free

Overview

Headquarters

C/o Switzerland Innovation Park Basel Ar...

Revenue

<$5 Million

Industry

Blood & Organ Banks Business Services Healthcare Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About InCephalo

InCephalo Therapeutics specializes in engineering compartment-locked biologics aimed at treating glioblastoma and other central nervous system diseases. Their innovative C-Lock technology allows for localized immune activation of brain tumors while minimizing systemic exposure risks. The company is focused on developing safe and effective biological treatments, with their lead asset, InC01, demonstrating significant potential in clinical trials. InCephalo aims to revolutionize CNS therapies and contribute to making brain cancer a curable disease.Explore more
InCephalo's Social MediaPopular SearchesInCephaloSIC Code 28,283NAICS Code 32,325Show more

Is InCephalo your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to InCephalo

Compare insights from companies similar to InCephalo, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

InCephalo

<$5M
1-10
Private
-
2021
N/A
$5.4M
11-50
Private
$20.2M
2003
SS
Steve SticeCo-Founder & Chief Scientific Officer
<$5M
11-50
Private
$45M
-
NY
Noymi YamVice President, Chief Scientific Officer
<$5M
1-10
Public
-
2012
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Public
$22.5M
2017
1-10
Public
$18M
1994
Joseph Tucker, Chief Executive Officer, Director at Enveric Biosciences
Joseph TuckerCEO, Director
Illustration of an envelope

Top Blood & Organ Banks Companies

Frequently Asked Questions Regarding InCephalo

What is InCephalo's official website?
InCephalo's official website is www.incephalo.com
What is InCephalo's Revenue?
InCephalo's revenue is <$5 Million
What is InCephalo's SIC code?
InCephalo's SIC: 28,283
What is InCephalo's NAICS code?
InCephalo's NAICS: 32,325
How many employees does InCephalo have?
InCephalo has 1-10 employees
What industry does InCephalo belong to?
InCephalo is in the industry of: Blood & Organ Banks, Business Services, Healthcare Services
What is InCephalo competition?
InCephalo top competitors include: CNS Pharmaceuticals, Go4cure, Cell Source, Enveric Biosciences
What does InCephalo do?

InCephalo Therapeutics specializes in engineering compartment-locked biologics aimed at treating glioblastoma and other central nervous system diseases. Their innovative C-Lock technology allows for localized immune activation of brain tumors while minimizing systemic exposure risks. The company is focused on developing safe and effective biologica... l treatments, with their lead asset, InC01, demonstrating significant potential in clinical trials. InCephalo aims to revolutionize CNS therapies and contribute to making brain cancer a curable disease.Read More

What are InCephalo social media links?
InCephalo Linkedin page
Is InCephalo a public company?
InCephalo is private company therefore does not currently have an official ticker symbol
See more information about InCephalo

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.